Literature DB >> 14770283

[Pain in multiple sclerosis--a still underestimated problem. The 1 year prevalence of pain syndromes, significance and quality of care of multiple sclerosis inpatients].

W Pöllmann1, W Feneberg, L-P Erasmus.   

Abstract

We evaluated the 1-year prevalence of pain syndromes and quality of care among 157 consecutive multiple sclerosis (MS) inpatients (90 f, 67 m) aged 19-85 years, with extended disability status scores of 1.0-8.5 and clinically definite MS. In a standardized questionnaire, only severe pain (pain intensity on visual analog scale of at least 4/10) was documented and classified which had occurred more often than three times or lasted longer than 1 week within the last year. Of 157 patients, 61% reported 176 pain syndromes: most frequent were headaches (40%), dysesthetic limb pain (19%), back pain (17%), and painful spasms (11%). Twelve percent of the pain syndromes were classified as worst symptom of MS, and in 68% insufficient care by the physicians consulted was reported. This was even true for the most frequent pain, migraine, in which clear treatment recommendations exist. There is thus an urgent need for physicians to keep this problem in mind when treating MS patients.

Entities:  

Mesh:

Year:  2004        PMID: 14770283     DOI: 10.1007/s00115-003-1656-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  20 in total

1.  Pain in chronic multiple sclerosis.

Authors:  M R Kassirer; D H Osterberg
Journal:  J Pain Symptom Manage       Date:  1987       Impact factor: 3.612

2.  Migraine and multiple sclerosis.

Authors:  S M Watkins; M Espir
Journal:  J Neurol Neurosurg Psychiatry       Date:  1969-02       Impact factor: 10.154

3.  Brain stem activation in spontaneous human migraine attacks.

Authors:  C Weiller; A May; V Limmroth; M Jüptner; H Kaube; R V Schayck; H H Coenen; H C Diener
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

4.  [Pain in the course of multiple sclerosis].

Authors:  Waldemar Fryze; Jacek Zaborski; Anna Członkowska
Journal:  Neurol Neurochir Pol       Date:  2002 Mar-Apr       Impact factor: 1.621

5.  The co-occurrence of multiple sclerosis and migraine headache: the serotoninergic link.

Authors:  R Sandyk; G I Awerbuch
Journal:  Int J Neurosci       Date:  1994-06       Impact factor: 2.292

Review 6.  Epidemiology of headache.

Authors:  B K Rasmussen
Journal:  Cephalalgia       Date:  1995-02       Impact factor: 6.292

7.  Acute demyelination mimicking vascular hemicrania.

Authors:  B J Nager; D J Lanska; R B Daroff
Journal:  Headache       Date:  1989-07       Impact factor: 5.887

8.  Acute and chronic pain syndromes in multiple sclerosis. A 5-year follow-up study.

Authors:  E Stenager; L Knudsen; K Jensen
Journal:  Ital J Neurol Sci       Date:  1995-12

9.  Vascular headache: a presenting symptom of multiple sclerosis.

Authors:  M S Freedman; T A Gray
Journal:  Can J Neurol Sci       Date:  1989-02       Impact factor: 2.104

10.  Pain syndromes in multiple sclerosis.

Authors:  D E Moulin; K M Foley; G C Ebers
Journal:  Neurology       Date:  1988-12       Impact factor: 9.910

View more
  5 in total

Review 1.  Headache in multiple sclerosis and autoimmune disorders.

Authors:  L La Mantia; V Prone
Journal:  Neurol Sci       Date:  2015-05       Impact factor: 3.307

2.  [Importance and treatment of spasticity in multiple sclerosis : results of the MOVE 1 study].

Authors:  T Henze; P Flachenecker; U K Zettl
Journal:  Nervenarzt       Date:  2013-02       Impact factor: 1.214

Review 3.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 4.  Headache and multiple sclerosis: clinical and therapeutic correlations.

Authors:  Loredana La Mantia
Journal:  Neurol Sci       Date:  2009-05       Impact factor: 3.307

5.  Pain in experimental autoimmune encephalitis: a comparative study between different mouse models.

Authors:  Jianning Lu; Martina Kurejova; Laura N Wirotanseng; Ralf A Linker; Rohini Kuner; Anke Tappe-Theodor
Journal:  J Neuroinflammation       Date:  2012-10-06       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.